Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5243]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
TAT 2017 congress provides the latest in Phase I targeted therapies
Professor Jean-Charles Soria - Gustave Roussy, Paris, France
TAT 2017 congress provides the latest in Phase I targeted therapies ( Professor Jean-Charles Soria - Gustave Roussy, Paris, France )
15 Nov 2016
Advances in malignant melanoma
Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Advances in malignant melanoma ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
11 Nov 2016
What involvement do stem cells have in disease and resistance?
Prof Andreas Trumpp - German Cancer Research Center, Heidelberg, Germany
What involvement do stem cells have in disease and resistance? ( Prof Andreas Trumpp - German Cancer Research Center, Heidelberg, Germany )
11 Nov 2016
How does the protein kinase Akt enable tumours to grow?
Dr Igor Vivanco - The Institute of Cancer Research, London, UK
How does the protein kinase Akt enable tumours to grow? ( Dr Igor Vivanco - The Institute of Cancer Research, London, UK )
11 Nov 2016
Using adoptive cell therapy to fight cancer
Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA
Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )
11 Nov 2016
History and progress of CD38 in myeloma
Dr Fabio Malavasi - University of Turin, Turin, Italy
History and progress of CD38 in myeloma ( Dr Fabio Malavasi - University of Turin, Turin, Italy )
2 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016
Drug combos with daratumumab likely to become standard of care in myeloma
Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland
Drug combos with daratumumab likely to become standard of care in myeloma ( Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland )
1 Nov 2016
New drugs and combinations in haematological cancers improve complete remission...
Dr Paolo Corradini - University of Milan, Milan, Italy
New drugs and combinations in haematological cancers improve complete remission rates ( Dr Paolo Corradini - University of Milan, Milan, Italy )
1 Nov 2016
CDK clinical trial results, benefit, side effects and costs
Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy
CDK clinical trial results, benefit, side effects and costs ( Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy )
26 Oct 2016
Extending indication of CDK 4/6 inhibitors in the adjuvant and neoadjuvant...
Dr Sara Hurvitz - UCLA Medical Center, Santa Monica, USA
Extending indication of CDK 4/6 inhibitors in the adjuvant and neoadjuvant setting ( Dr Sara Hurvitz - UCLA Medical Center, Santa Monica, USA )
26 Oct 2016
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers
Dr Sibylle Loibl - German Breast Cancer Group
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers ( Dr Sibylle Loibl - German Breast Cancer Group )
26 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation